Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Employer
- City of Hope
- University of British Columbia
- Michigan State University
- Dana-Farber Cancer Institute (DFCI)
- National University of Singapore
- New England HERC
- University of Maryland, Baltimore
- University of Birmingham
- Baylor College of Medicine
- Indiana University
- King's College London
- Saint Louis University
- University of Colorado
- University of Copenhagen
- Aarhus University
- Albert Einstein College of Medicine (Bronx, NY)
- Boehringer Ingelheim International GmbH
- Cleveland Clinic
- Ellison Institute of Technology
- Francis Crick Institute
- Johns Hopkins Medicine - Laboratory of Human Biomimetics
- La Jolla Institute for Immunology - Human Resources
- Luxembourg Institute of Health (LIH)
- MD Anderson Cancer Center - Department of Lymphoma/Myeloma
- MRC Laboratory of Medical Sciences
- Mayo Clinic
- Mayo Clinic, Rochester
- Microbiomes Institute — University of South Florida
- Nanyang Technological University
- National Institutes of Health (NIH)
- Northeastern University
- Pennsylvania State University
- St Jude Children's Research Hospital
- THE UNIVERSITY OF HONG KONG
- The Francis Crick Institute
- The University of Queensland
- The University of Texas MD Anderson Cancer Center
- UCL
- UNIVERSITY OF WISCONSIN-MADISON Biomolecular Chemistry
- Umeå University
- Univ. Alabama, Birmingham
- University of Aberdeen
- University of Basel
- University of British Columbia - Department of Medicine
- University of Lund
- University of North Carolina at Charlotte
- 36 more »
- « less
-
Field
-
receptors expressed by CD4+CD28null T cells in atherosclerotic plaque instability. They will use multiparameter immunophenotyping, functional T-cell assays, spatial transcriptomics and multiplex
-
the field of pulmonary fibrosis using animal and primary cell culture models, single-cell, and spatial transcriptomics approaches. The successful candidate will be expected to build a publication
-
executes experiments using mouse models that includes breeding colony management and genotyping. Performs advanced 3D and spatial imaging (confocal, LSFM, Xenium spatial transcriptomics) and
-
The lab employs cutting-edge technologies (immunopeptidomics, T cell engineering, single-cell transcriptomics, spatial transcriptomics, CRISPR technologies) paired with in vivo animal model systems and
-
drug treatments through multiomic analyses, including chromatin profiling, single-cell sequencing, and spatial transcriptomics, using samples derived directly from clinical trials. The successful
-
cells and tissues in three dimensions. Working across two exemplar disease areas, we will integrate clinical and medical imaging, with spatial transcriptomics and multi-omics multiplex imaging and
-
analysis. Research areas may include method development for studying the tumour microenvironment using spatial transcriptomics, integrative proteogenomics for causal inference, and AI-driven models for
-
, tissue-specific regulatory programs, and physiological responses to exercise. Candidates with expertise in multi-omics integration, single-cell and long-read transcriptomics are particularly encouraged
-
interactions can contribute to food protection and reduced food loss. BIOBARRIER combines microbial ecology, molecular microbiology, transcriptomics, metabolomics, and computational approaches to
-
contribute to NIH-funded research focused on the molecular mechanisms underlying endometrial function and endometriosis. This position will support projects integrating spatial transcriptomics, single-cell